| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |